Analysts Set Intuitive Surgical Inc. (NASDAQ:ISRG) Price Target at $723.13
Intuitive Surgical Inc. (NASDAQ:ISRG) has earned an average recommendation of “Buy” from the twenty research firms that are covering the firm. One investment analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and thirteen have given a buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $723.13.
ISRG has been the subject of several recent research reports. Evercore ISI restated a “buy” rating and set a $775.00 target price (up previously from $750.00) on shares of Intuitive Surgical in a report on Wednesday, July 20th. Zacks Investment Research cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, September 20th. Citigroup Inc. restated a “buy” rating on shares of Intuitive Surgical in a report on Thursday, June 2nd. Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $700.00 to $800.00 and gave the stock a “buy” rating in a report on Wednesday, July 20th. Finally, Goldman Sachs Group Inc. cut shares of Intuitive Surgical from a “buy” rating to a “neutral” rating and increased their target price for the stock from $633.00 to $674.00 in a report on Thursday, June 2nd. They noted that the move was a valuation call.
Shares of Intuitive Surgical (NASDAQ:ISRG) opened at 719.99 on Tuesday. The firm has a market capitalization of $27.71 billion, a price-to-earnings ratio of 40.86 and a beta of 0.73. The firm has a 50-day moving average of $692.73 and a 200 day moving average of $653.98. Intuitive Surgical has a 52-week low of $447.00 and a 52-week high of $724.00.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 19th. The company reported $5.62 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $4.97 by $0.65. Intuitive Surgical had a net margin of 26.80% and a return on equity of 15.25%. The business earned $670 million during the quarter, compared to analysts’ expectations of $640.69 million. During the same quarter in the prior year, the company posted $4.57 earnings per share. Analysts predict that Intuitive Surgical will post $21.30 EPS for the current year.
In related news, SVP Mark J. Meltzer sold 3,000 shares of the firm’s stock in a transaction dated Monday, August 22nd. The shares were sold at an average price of $688.33, for a total transaction of $2,064,990.00. Following the transaction, the senior vice president now directly owns 2,331 shares of the company’s stock, valued at $1,604,497.23. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 13,400 shares of the firm’s stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $698.00, for a total transaction of $9,353,200.00. Following the transaction, the chief executive officer now directly owns 78,780 shares in the company, valued at $54,988,440. The disclosure for this sale can be found here. Corporate insiders own 3.10% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the company. Adage Capital Partners GP L.L.C. increased its stake in shares of Intuitive Surgical by 0.3% in the first quarter. Adage Capital Partners GP L.L.C. now owns 55,629 shares of the company’s stock worth $33,436,000 after buying an additional 164 shares during the last quarter. Strs Ohio increased its stake in shares of Intuitive Surgical by 6,226.9% in the second quarter. Strs Ohio now owns 47,895 shares of the company’s stock worth $31,678,000 after buying an additional 47,138 shares during the last quarter. Babson Capital Management LLC increased its stake in shares of Intuitive Surgical by 96.8% in the first quarter. Babson Capital Management LLC now owns 3,416 shares of the company’s stock worth $2,053,000 after buying an additional 1,680 shares during the last quarter. Legal & General Group Plc increased its stake in shares of Intuitive Surgical by 2.9% in the first quarter. Legal & General Group Plc now owns 157,808 shares of the company’s stock worth $94,849,000 after buying an additional 4,398 shares during the last quarter. Finally, AMP Capital Investors Ltd increased its stake in shares of Intuitive Surgical by 27.0% in the first quarter. AMP Capital Investors Ltd now owns 15,995 shares of the company’s stock worth $9,570,000 after buying an additional 3,400 shares during the last quarter. 91.90% of the stock is currently owned by institutional investors and hedge funds.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.